Luye Medical Group adopts Cleveland Clinic’s Connected international programme
Recently adopting Apple’s Health Records to provide care which is increasingly patient centered and connected, the Cleveland Clinic have now partnered with Luye Medical Group in a new value-based collaboration.
As part of its ‘Healthy China 2030’ vision to establish a cluster of specialty groups, Luye Medical Group aims to bring exceptional healthcare services to Shanghai New Hong Qiao International Medical Center, with a focus on overall wellness, quality of care, and preventive screenings.
The collaboration will also introduce specialties, such as cardiology, urology, and oncology.
Headquartered in Singapore, Luye Medical oversees over 50 private healthcare organisations, from China, Australia and Singapore, to South Korea and New Zealand. In China, the organisation has established specialty areas and integrated services in Shanghai, Yantai, Chongqing and Chengdu.
A member of the Cleveland Clinic’s Connected international programme, which enables patients around the world to connect with its best practices and leading-edge technology, hospitals are able to deliver exceptional health services.
- Cleveland Clinic harnesses Apple’s Health Records, promoting patient record accessibility
- Research on the benefits of 3D printing in a trauma hospital
- idsMED and WeDoctor launch China’s first Smart Medical Supply Chain and Procurement company
Through the programme, patients located in Shanghai will also gain access to detailed health education materials prepared by experts at Cleveland Clinic regarding various conditions and treatments on offer.
“With strong government support, Shanghai New Hong Qiao International Medical Center is positioned to be the pilot zone for national and Shanghai medical reform,” said Jie Yang, Chairman of Shanghai New Hong Qiao International Medical Center Construction Development Co. Ltd.
The collaboration between Luye Medical and Cleveland Clinic is expected to pave the way in developing a premium innovation healthcare hub and a high-end medical service platform based in Shanghai that can extend to the Yangtze River Delta, and service the whole country.”
“With our shared vision, we will strive for delivering world-class healthcare innovation and expertise to have a profound impact on the well-being of local community,” added Liu Dianbo, Chairman of the Board and President of Luye Life Sciences Group.
“As the collaboration advances, we look forward to working closely with public hospitals and universities to drive innovation with ‘hospital of the future’ collaboration centers and deliver international-level clinical outcomes and value to patients locally and nationally.”
A third of UK patients prefer mobile apps to doctor visits
A third of UK patients prefer using mobile healthcare applications to having face-to-face consultations, a new report has found.
The research, commissioned by Mobiquity and conducted by Censuswide, surveyed 100 doctors and 1,003 patients in the UK during COVID-19 to understand their experiences with digital healthcare technology and its impact on patient care.
It found that as a result of COVID-19, 33% of patients would rather use a mobile app than visit the doctor.
Additionally over a third of doctors said that using mobile healthcare applications made it easier to prescribe the right treatment for patients remotely. However respondents cited technical issues and privacy concerns as barriers to using mobile healthcare apps.
The survey's other findings include:
* 56% of UK patients plan to use mobile healthcare applications in the future after using them during COVID-19.
* 71% of doctors plan to adopt mobile healthcare applications in the future
*52% of doctors experienced technical issues, with device compatibility problems being the most frequently reported technical issue
*28% of patients cited privacy concerns when using mobile healthcare applications during COVID-19
Commenting on the report, Teun Schutte, Managing Consultant at Mobiquity said that the COVID-19 pandemic had been transformational for digital healthcare. "The pandemic has shown the importance of digital health solutions and the need for increased adoption in the future, while at the same time highlighting the benefits around ease of access to care for patients and lower costs for healthcare providers.
“The challenge that exists, however, is how to solve frictions in the delivery of mobile healthcare applications and other types of digital health in the future. Our research highlighted the main barriers to adoption for patients and practitioners, and the areas we need to optimise to ensure digital innovation is scaled successfully to improve patient outcomes. Indeed, technical issues and privacy concerns need to be solved by aligning stakeholder concerns before digital health products are launched" he added.
“By aligning the digital innovation process and creating a blueprint for scaling the next generation of digital health technologies, as an industry we can scale digital health products or services across disease areas, and across hospitals, markets and regions, ensuring that patients receive personalised, quality care through digital health technologies.”